MedPath

Product Feasibility of a New Silicone Hydrogel Contact Lens

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Investigational Lens
Device: Acuvue Oasys Lens
Device: Air Optix Aqua Lens
Registration Number
NCT01309100
Lead Sponsor
Bausch & Lomb Incorporated
Brief Summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lens.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
144
Inclusion Criteria
  • Subjects must have clear central corneas and be free of any anterior segment disorders.
  • Subjects must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Subjects must be myopic and require lens correction
Exclusion Criteria
  • Subjects with any systemic disease affecting ocular health.
  • Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Subjects with an active ocular disease or are using any ocular medication.
  • Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Investigational LensInvestigational LensBausch \& Lomb investigational silicone hydrogel lens.
Acuvue Oasys LensAcuvue Oasys LensJohnson \& Johnson Acuvue Oasys contact lens.
Air Optix Aqua LensAir Optix Aqua LensCiba Vision Air Optix Aqua contact lens.
Primary Outcome Measures
NameTimeMethod
Visual Acuity (Investigational vs Air Optix Aqua Lens)1 week

The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens (RD2117-01) and the Air Optix Aqua control lens.

Visual Acuity (Investigational vs Acuvue Oasys Lens)1 week

The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens(RD2117-01) and the Acuvue Oasys control lens.

Secondary Outcome Measures
NameTimeMethod
Comfort Throughout the Day (Investigational vs Acuvue Oasys Lens)1 week

The mean differences in comfort between the investigational lens (RD2117-01) and the Acuvue Oasys control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.

Comfort Throughout the Day (Investigational vs Air Optix Aqua Lens)1 week

The mean differences in comfort between the investigational lens(RD2117-01) and the Air Optix Aqua control lens. Comfort was measured on a scale of 0 to 100, with 100 being the most favorable score.

Trial Locations

Locations (1)

Bausch & Lomb Incorporated

🇺🇸

Rochester, New York, United States

© Copyright 2025. All Rights Reserved by MedPath